Company Filing History:
Years Active: 2015-2017
Title: Innovations of Bingqiang Kang in Pharmaceutical Development
Introduction
Bingqiang Kang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target DNA repair mechanisms. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Kang's latest patents include a poly (ADP-ribose) polymerase inhibitor. This invention discloses a phthalic hydrazide (phthalazine ketone) compound, along with a pharmaceutical composition that incorporates this compound. The significance of this invention lies in its potential to effectively treat diseases that involve PARP enzymatic activity, such as cancer, neurodegenerative diseases, and inflammation.
Career Highlights
Bingqiang Kang is currently associated with Chengdu Di'ao Pharmaceutical Group Co., Ltd. His role in this company allows him to further his research and development efforts in the pharmaceutical industry. His innovative approach and dedication to improving health outcomes have made him a valuable asset in his field.
Collaborations
Kang collaborates with esteemed colleagues, including Jianxin Ji and Na Guo. Their combined expertise enhances the research and development processes within their projects.
Conclusion
Bingqiang Kang's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His work on poly (ADP-ribose) polymerase inhibitors showcases the potential for new treatments in critical health areas.